Skip to main content
Sanofi (SNYNF)
OTCMKTS · Delayed Price · Currency is USD
95.06
+2.62 (2.83%)
Apr 27, 2026, 9:30 AM EST

Sanofi Statistics

Total Valuation

Sanofi has a market cap or net worth of 111.77 billion. The enterprise value is 129.15 billion.

Market Cap 111.77B
Enterprise Value 129.15B

Important Dates

The last earnings date was Thursday, April 23, 2026.

Earnings Date Apr 23, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 1.21B
Shares Outstanding n/a
Shares Change (YoY) -2.73%
Shares Change (QoQ) -0.70%
Owned by Insiders (%) 0.02%
Owned by Institutions (%) 47.34%
Float 1.09B

Valuation Ratios

The trailing PE ratio is 12.83 and the forward PE ratio is 9.24.

PE Ratio 12.83
Forward PE 9.24
PS Ratio 2.05
PB Ratio 1.33
P/TBV Ratio 26.05
P/FCF Ratio 11.30
P/OCF Ratio 9.38
PEG Ratio n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 8.53, with an EV/FCF ratio of 13.06.

EV / Earnings 14.83
EV / Sales 2.32
EV / EBITDA 8.53
EV / EBIT 11.57
EV / FCF 13.06

Financial Position

The company has a current ratio of 1.01, with a Debt / Equity ratio of 0.27.

Current Ratio 1.01
Quick Ratio 0.20
Debt / Equity 0.27
Debt / EBITDA 1.53
Debt / FCF 2.33
Interest Coverage 18.84

Financial Efficiency

Return on equity (ROE) is 6.43% and return on invested capital (ROIC) is 9.38%.

Return on Equity (ROE) 6.43%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 9.38%
Return on Capital Employed (ROCE) 9.90%
Weighted Average Cost of Capital (WACC) 5.34%
Revenue Per Employee 729,489
Profits Per Employee 116,385
Employee Count 74,846
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Sanofi has paid 1.13 billion in taxes.

Income Tax 1.13B
Effective Tax Rate 16.83%

Stock Price Statistics

The stock price has decreased by -10.13% in the last 52 weeks. The beta is 0.32, so Sanofi's price volatility has been lower than the market average.

Beta (5Y) 0.32
52-Week Price Change -10.13%
50-Day Moving Average 92.58
200-Day Moving Average 97.08
Relative Strength Index (RSI) 56.10
Average Volume (20 Days) 1,747

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Sanofi had revenue of 54.60 billion and earned 8.71 billion in profits. Earnings per share was 7.15.

Revenue 54.60B
Gross Profit 39.51B
Operating Income 11.19B
Pretax Income 6.73B
Net Income 8.71B
EBITDA 14.79B
EBIT 11.19B
Earnings Per Share (EPS) 7.15

Balance Sheet

The company has 6.39 billion in cash and 23.08 billion in debt, giving a net cash position of -16.69 billion.

Cash & Cash Equivalents 6.39B
Total Debt 23.08B
Net Cash -16.69B
Net Cash Per Share n/a
Equity (Book Value) 84.33B
Book Value Per Share 69.71
Working Capital 179.87M

Cash Flow

In the last 12 months, operating cash flow was 11.92 billion and capital expenditures -2.03 billion, giving a free cash flow of 9.89 billion.

Operating Cash Flow 11.92B
Capital Expenditures -2.03B
Depreciation & Amortization 3.65B
Net Borrowing 1.76B
Free Cash Flow 9.89B
FCF Per Share n/a

Margins

Gross margin is 72.36%, with operating and profit margins of 20.49% and 15.95%.

Gross Margin 72.36%
Operating Margin 20.49%
Pretax Margin 12.32%
Profit Margin 15.95%
EBITDA Margin 27.09%
EBIT Margin 20.49%
FCF Margin 18.11%

Dividends & Yields

Sanofi does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 63.16%
Buyback Yield 2.73%
Shareholder Yield 2.73%
Earnings Yield 7.79%
FCF Yield 8.85%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 4